Literature DB >> 27928304

Bilateral Inflammatory Optic Neuropathy Related to Graft versus Host Disease Following Allogeneic Bone Marrow Transplantation for Hodgkin Disease.

I Moesen1, D P Kidd1.   

Abstract

Graft versus host disease (GvHD) is a common and often troublesome complication of allogeneic bone marrow transplantation. Neurological complications usually involve the peripheral nervous system and muscle, but the central nervous system may be affected. When an optic neuropathy develops, it is often difficult to determine the cause quickly; infective complications and drug toxicity may have arisen, but an inflammatory disorder due to GvHD should also be considered, particularly since treatment with steroids and immune suppression may improve the outcome significantly. This brief case report shows how this may be the case and reviews our current understanding of the pathophysiology and treatment of the disorder within the nervous system.

Entities:  

Keywords:  Graft versus host disease; optic neuritis; optic neuropathy

Year:  2014        PMID: 27928304      PMCID: PMC5123097          DOI: 10.3109/01658107.2014.907321

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  17 in total

Review 1.  Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.

Authors:  Oliver Grauer; Daniel Wolff; Hartmut Bertz; Hildegard Greinix; Jörn-Sven Kühl; Anita Lawitschka; Stephanie J Lee; Steven Z Pavletic; Ernst Holler; Ingo Kleiter
Journal:  Brain       Date:  2010-09-15       Impact factor: 13.501

2.  Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.

Authors:  Ali G Saad; Edwin P Alyea; Patrick Y Wen; Umberto Degirolami; Santosh Kesari
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

3.  Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation.

Authors:  Xiaolei Shao; Zhijun He; Luosheng Tang; Ling Gao
Journal:  Transplantation       Date:  2012-11-15       Impact factor: 4.939

4.  Prospective evaluation of neurological complications after allogeneic bone marrow transplantation.

Authors:  P Sostak; C S Padovan; T A Yousry; G Ledderose; H-J Kolb; A Straube
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

5.  Unilateral tacrolimus-associated optic neuropathy after liver transplantation.

Authors:  Francisco J Ascaso; Javier Mateo; Valentin Huerva; José A Cristóbal
Journal:  Cutan Ocul Toxicol       Date:  2011-10-28       Impact factor: 1.820

6.  Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity.

Authors:  Sriram Venneti; Heather E Moss; Marc H Levin; M Reza Vagefi; Susan C Brozena; Amy A Pruitt; Zissimos Mourelatos; John Q Trojanowski; Steven L Galetta; Laura J Balcer
Journal:  J Neurol Sci       Date:  2010-11-26       Impact factor: 3.181

7.  Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria.

Authors:  R Jacobs; U Tran; H Chen; A Kassim; B G Engelhardt; J P Greer; S G Goodman; C Clifton; C Lucid; L A Vaughan; B N Savani; M Jagasia
Journal:  Bone Marrow Transplant       Date:  2012-04-09       Impact factor: 5.483

8.  Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures.

Authors:  J W McDonald; M P Goldberg; B J Gwag; S I Chi; D W Choi
Journal:  Ann Neurol       Date:  1996-11       Impact factor: 10.422

9.  Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.

Authors:  Anna Maria Delios; Marc Rosenblum; Ann A Jakubowski; Lisa M DeAngelis
Journal:  J Neurooncol       Date:  2012-08-23       Impact factor: 4.130

10.  Cerebral angiitis in four patients with chronic GVHD.

Authors:  P Sostak; C S Padovan; S Eigenbrod; S Roeber; S Segerer; C Schankin; S Siegert; T Saam; D Theil; H-J Kolb; H Kretzschmar; A Straube
Journal:  Bone Marrow Transplant       Date:  2009-11-16       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.